Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PRAMLINTIDE vs PRAVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PRAMLINTIDE vs PRAVASTATIN: Safety Overview

Metric PRAMLINTIDE PRAVASTATIN
Total FAERS Reports 332 8,284
Deaths Reported 4 923
Death Rate 1.2% 11.1%
Hospitalizations 19 2,338
Average Patient Age 58.6 yrs 65.5 yrs
% Female Patients 75.3% 55.0%
FDA Approval Date Mar 16, 2005 Apr 13, 2018
Manufacturer AstraZeneca Pharmaceuticals LP Northwind Health Company, LLC
Route SUBCUTANEOUS ORAL
Marketing Status Discontinued Discontinued